ALSO NOTED: Akzo agrees on Remeron settlement; Isis grants drug license; KV gets OK in Singapore; and much more...

> Akzo Nobel will pay out $75 million to settle remaining claims that the company improperly delayed the release of a generic version of its antidepressant Remeron. Story

> Isis Pharmaceuticals of Vancouver has granted an exclusive license to iCo to develop its antisense drug ISIS 13650. Release

> KV Pharmaceutical has received approval to market its vaginal cream Gynazole in Singapore. Release

> Regeneration Technologies is raising $23.9 million through a private placement. Release

> American Pharmaceutical Partners says that its planned renovation of its Melrose Park, Illinois, manufacturing plant will take longer than anticipated. Release

And Finally… The FDA is reviewing how to regulate renewed use of leeches and maggots in healthcare. Article